Oliver Gautschi

The value of ultrasound-guided biopsy of fluorodeoxy-glucose positron emission tomography (FDG-PET)-positive supraclavicular lymph nodes in patients with suspected lung cancer

Justus E. Roos, Lennart Werner, Franziska Aebersold Keller, 2017, BMC Medical Imaging.

Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.

Walter Weder, Oliver Gautschi, R. Stahel, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

Ross Camidge, Vamsidhar Velcheti, Thomas Filleron, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.

Oliver Gautschi, J. Heighway, D. Betticher, 2007, Lung cancer.

Aurora Kinases as Anticancer Drug Targets

Oliver Gautschi, D. Gandara, J. Heighway, 2008, Clinical Cancer Research.

Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08).

Ruedi Aebersold, Christian Rothermundt, Peter J Wild, 2013, European urology.

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort

Bastien Cabarrou, Thomas Filleron, Juergen Wolf, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.